Abstract:
One or more embodiments include a method of delivering a pharmaceutical product via a medium. The pharmaceutical product is associated with the medium and the medium assumes different values based on predetermined business rules. The method includes generating data in a database associated with a central computing station where the data identifies the medium and the product associated with the medium. The database is provisioned with the rules that determine the value of the medium. In response to the holder presenting the medium to a provider of the product for purposes of obtaining the product, a communication from the provider is received identifying the medium. A value for the medium is established based on the rules provisioned in the database. The value of the medium is updated, and that updated value is recorded in the database in response to the provider providing the product to the holder of the medium.
Abstract:
A method of distributing and tracking donated prescription medicines includes a pharmaceutical donor donating in-kind pharmaceutical products to a non-profit organization which then transfers the donated pharmaceutical products to a pharmaceutical distributor. An electronic record is established indicating a credit with pharmaceutical distributor in favor of the non-profit organization. After a pharmacy has distributed a pharmaceutical to an eligible patient, the pharmacy notifies the non-profit organization of the transaction and the non-profit organization authorizes the pharmaceutical distributor to apply to the credit to the benefit of the pharmacy.
Abstract:
A method for distributing a prescription pharmaceutical product includes recording a unique identifier in a database that identifies a medium and a prescription pharmaceutical product associated with the medium. The database is provisioned with criteria that establish different potential values for the medium. Thus, the medium has a variable value that varies according to the criteria provisioned in the database. A holder of the medium then presents the medium to a provider of the prescription pharmaceutical product. Upon receipt the medium, the provider communicates the unique identifier associated with the medium. Based on the unique identifier of the medium and the variable value criteria provisioned in the database, the value of the medium is determined and communicated to the provider. The holder then utilizes the determined value to purchase the prescription pharmaceutical product associated with the medium.
Abstract:
A method is disclosed for controlling a lighting fixture of a kind having individually colored light sources, e.g., LEDs, that emit light having a distinct luminous flux spectrum that varies in its initial spectral composition, that varies with temperature, and that degrades over time. The method controls such fixture so that it projects light having a predetermined desired flux spectrum despite variations in initial spectral characteristics, despite variations in temperature, and despite flux degradations over time.
Abstract:
An improved lighting apparatus, suitable for use as part of a lighting fixture, is disclosed, having a plurality of groups of distinct light-emitting devices, e.g., light-emitting diodes, that can be controlled to produce a beam of light having a wide variety of complex luminous flux spectra, including, but not limited, to spectra that closely emulate that of any one of a number of conventional light sources, with or without a conventional chemical dye filter. Each group of light-emitting devices is configured to emit light having a distinct luminous flux spectrum. A controller supplies selected amounts of electrical power to two or more groups of the plurality of groups of light-emitting devices, such that the groups cooperate to produce a composite beam of light having a selected luminous flux spectrum. The spectrum can be controlled to have a normalized mean deviation across the visible spectrum, relative to that of a beam of light to be emulated, of less than about 30%. This a marked improvement over all known lighting fixtures of the kind including multiple groups of distinct light sources. The groups of light-emitting devices are configured to include independently selected quantities of devices. Further, the groups of light-emitting devices are configured to each have a spectral half-width of less than about 40 nanometers (nm) and to have a peak flux wavelength that is spaced less than about 50 nm from that of an adjacent group.
Abstract:
A new and improved method of dispensing, tracking and managing pharmaceutical product samples by communicatively linking prescribers and pharmacies to a central computing station. The method entails utilizing product trial media that is exchanged for actual pharmaceutical product. The media is encoded with information that identifies a particular pharmaceutical trial product, such as by magnetic encoding similar to that used with credit cards. The media is distributed to participating medical doctors or prescribers who then activate the media via the central computing station. The prescriber then transfers the activated media to patients who then present the media to participating pharmacies. Before filling the pharmaceutical trial product identified by the media, the pharmacy validates the media via a link with the central computing station. Then, the pharmacy dispenses the prescribed pharmaceutical trial product. The central computing station also includes a database that records data related to the use of the media so that all pharmaceutical trial products can be accounted for.
Abstract:
A dimming control circuit for a plurality of lighting fixtures includes a separate semiconductor power switch, e.g., a silicon-controlled rectifier or SCR, for providing controlled amounts of pulsed, unidirectional electrical current to each lighting fixture. In one embodiment, a pair of SCRs, arranged in parallel, opposed relationship, are controllably pulsed to produce an alternating sequence of positive and negative electrical current pulses, of independently-controlled duration, and oppositely-conducting diodes then connect these SCRs to two separate lighting fixture. One such lighting fixture thus receives the positive current pulses, and the other such lighting fixture thus receives the negative current pulses. In an alternative embodiment, each lighting fixture receives pulsed, unidirectional current directly from a separate, independently-controlled SCR.
Abstract:
A circuit and a method for controlling the dimming of incandescent lights using a pair of antiparallel connected SCRs which are fired at the same frequency as the frequency of the AC line power to achieve phase control of the power supplied to the light. Only one SCR of the pair is utilized in the 0% to 50% brightness range while both SCRs are utilized in the 51% to 100% brightness range.
Abstract:
An improved LED light source assembly is described, suitable for use as a retrofit for prior lighting fixtures of a kind including a concave reflector, an incandescent lamp positioned with its filament(s) at or near a focal region of the reflector, and a lens assembly for projecting light reflected by the reflector to a distant location, e.g., a theater stage. The improved LED light source assembly includes a compact arrangement of three or more LED assemblies, which are mounted at the forward end of an elongated heat pipe. The heat pipe's rearward end attaches to a heat sink mountable on the back side of the lighting fixture's concave reflector, and the heat pipe extends through a central hole in the reflector to position the LED assemblies at or near the concave reflector's focal region. The concave reflector reflects light emitted by the LED assemblies forward to the lighting fixture's lens assembly, which in turn projects a beam of light to a distant location. The LED light engine's configuration allows a significant proportion of the prior lighting fixture to continue to be utilized, leading to substantial cost saving and simplified installation.
Abstract:
A method implemented by a trusted third-party computing system assists a manufacturer of a prescription pharmaceutical product to promote that product by authorizing a pharmacy that makes one or more sales of the product to make one or more future purchases on promotional payment terms. The method includes receiving one or more electronic notifications that indicate the pharmacy has made one or more sales of the prescription pharmaceutical product to one or more patients, and then validating that the one or more indicated sales have actually occurred. Validation may entail validating data fields in each received notification and/or validating that the one or more sales are consistent with the pharmacy's inventory. Responsive to this validation, the method includes generating and sending control signalling based on the one or more indicated sales for triggering the manufacturer to authorize the pharmacy to make one or more future purchases on promotional payment terms.